FRT
39
-4
MNST
47
-2
WDC
49
-3
RF
51
-2
MU
35
-7
BRK.B
31
-2
NOV
40
-2
SYY
50
-3
NWS
60
-2
GOOGL
67
8
DVN
18
-3
HPE
40
-13
PAYX
50
3
LRCX
59
-5
KMI
65
-4
T
47
2
FLS
69
-2
BA
63
5
ESS
57
-2
PSX
35
-5
FRT
39
-4
MNST
47
-2
WDC
49
-3
RF
51
-2
MU
35
-7
BRK.B
31
-2
NOV
40
-2
SYY
50
-3
NWS
60
-2
GOOGL
67
8
DVN
18
-3
HPE
40
-13
PAYX
50
3
LRCX
59
-5
KMI
65
-4
T
47
2
FLS
69
-2
BA
63
5
ESS
57
-2
PSX
35
-5
Financhill
Back

Hansa Biopharma AB Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
39

HNSBF
Hansa Biopharma AB

Last Price:
2.83
Seasonality Move:
-0.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE

Hansa Biopharma AB Price Quote

$2.83

Hansa Biopharma AB Key Stats

Sell
39
Hansa Biopharma AB (HNSBF) is a Sell
Day range:
$2.83 - $2.83
52-week range:
$2.26 - $3.65
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.25
P/B ratio:
0%
Volume:
0
Avg. volume:
67
1-year change:
-5.67%
Market cap:
$185.7M
Revenue:
$12.7M
EPS:
$-1.08

How Much Does Hansa Biopharma AB Make?

Is Hansa Biopharma AB Growing As A Company?

  • What Is Hansa Biopharma AB's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.21%
  • What Is Hansa Biopharma AB's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Hansa Biopharma AB Stock Price Performance

What Is Hansa Biopharma AB 52-Week High & Low?

Hansa Biopharma AB Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Hansa Biopharma AB?

  • How Much Debt Does Hansa Biopharma AB Have?
    Total long term debt quarterly is $93.5M
  • How Much Cash Does Hansa Biopharma AB Have?
    Cash and short term investments quarterly total is $54.9M
  • What Is Hansa Biopharma AB’s Book Value Per Share?
    Book value per share is -0.48

Is Hansa Biopharma AB Cash Flow Positive?

  • What Is HNSBF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$68.1M
  • What Is Hansa Biopharma AB’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $33.4M
  • What Is Hansa Biopharma AB’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $25.9K

Hansa Biopharma AB Return On Invested Capital

  • Is Management Doing A Good Job?
    HNSBF return on invested capital is -95.02%
  • What Is Hansa Biopharma AB Return On Assets?
    ROA measures how assets are converting to revenues and is -65.34%
  • What Is HNSBF Return On Equity?
    ROE is a measure of profitability and is 0%

Hansa Biopharma AB Earnings Date & Stock Price

Hansa Biopharma AB Competitors

Hansa Biopharma AB Dividend Yield

Hansa Biopharma AB Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 121.5% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many HNSBF shares are owned by institutional investors?
    2.9M HNSBF shares are owned by institutional investors
  • How many HNSBF shares are owned by insiders?
    0 HNSBF shares are owned by insiders